Transfection Technologies Market- Growth, Trends, and Forecast (2022 - 2027)

Transfection Technologies Market- Growth, Trends, and Forecast (2022 - 2027)

The transfection technologies market will show a rapid growth due to the rising incidences of cancer and the increase in research & development in the field of cell based therapies.

As there is increasing prevalence of cancer and growing number of the obese population, there is a rising demand for transfection. This factor is driving the transfection technologies market. In addition, initiatives taken by various government organizations further accentuates the growth of this market. However, the high cost of instruments may restrain the overall market growth in the years to come.

Key Market TrendsReagent-based Method is Showing Significant Growth in the Transfection Technologies Market

Reagent based transfection technology market is experiencing significant growth owing to cost effectiveness and less complicated methods involved during transfection. Likewise, instrument-based method includes electroporation, biolistic technology, microinjection and laserfection. Instrument-based methods are also less time consuming and accurate and all these advantages drives the growth of this segment.

North America is Found Leading the Transfection Technologies Market

North America is found dominating the market, that is driven by factors such as increasing cases of infectious diseases demanding the need of antibiotics and the growing use of cell-based products which require transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases. The United States and Canada are the major consumers of transfection technologies in this region.

Asia Pacific is also estimated to grow at the highest CAGR, as the developing countries like India and China are the major consumers of transfection technologies in this region.

Competitive Landscape

The global transfection technologies market is concentrated with international and regional companies that offer products for different types of transfection methods for pharmaceutical and biotechnology companies, contract research organizations (CRO), and academic and research institutes.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Lonza Group
Bio
Rad Laboratories, Inc.
Thermo Fisher Scientific
Qiagen NV
Promega Corporation
SignaGen Laboratories
Merck KGaA
Altogen Biosystems
Polyplus
transfection SA
Mirus Bio

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.